The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a prognostic nomogram for liver toxicity in patients treated with pazopanib.
 
Michael W. Kattan
Consulting or Advisory Role - GlaxoSmithKline
 
Winette T.A. Van Der Graaf
Speakers' Bureau - Lilly
Research Funding - GlaxoSmithKline; Novartis
 
Thomas Powles
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
 
Simon Lam
No Relationships to Disclose
 
Qasim Ahmad
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
Other Relationship - Novartis
 
Luca Dezzani
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
Other Relationship - Novartis
 
Jackie Han
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Cora N. Sternberg
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi